LYRCX | VMVAX | LYRCX / VMVAX | |
Total Expense Ratio | 1.99 | 0.07 | 2,843% |
Annual Report Gross Expense Ratio | 2.46 | 0.07 | 3,514% |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 5.680 | -1.348 | -421% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.04B | 29.1B | 4% |
Annual Yield % from dividends | 0.00 | 2.40 | - |
Returns for 1 year | 10.89 | 5.04 | 216% |
Returns for 3 years | N/A | 15.40 | - |
Returns for 5 years | N/A | 76.97 | - |
Returns for 10 years | N/A | 75.63 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPEM | 41.63 | 0.16 | +0.39% |
SPDR® Portfolio Emerging Markets ETF | |||
CGW | 60.56 | 0.18 | +0.30% |
Invesco S&P Global Water ETF | |||
GEMD | 39.87 | 0.04 | +0.10% |
Goldman Sachs Access Emrg Mkts USD BdETF | |||
LEMB | 39.04 | N/A | N/A |
iShares JP Morgan EM Local Ccy Bd ETF | |||
PSMO | 27.83 | N/A | N/A |
Pacer Swan SOS Moderate (October) ETF |